Ospolot—A Clinical Trial of a New Anticonvulsant

Abstract
Ospolot is tetrahydro-2-p-sulphamoylphenyl-1, 2 thiazine 1, 1-dioxide, with a structural formula:

This publication has 1 reference indexed in Scilit: